PLA1A and neoplasm: Six tumor antigens (HP1BP3, OSBPL9, SSH3, ZCCHC8, FANCI and EIF4A2) were correlated with the expression of NMD factors and infiltration of APCs, which may be promising candidates for mRNA vaccines.